第四届国际药物代谢学会/中国药代专业委员会学术会议
各位老师、同学、同事和同仁:
根据国际药代学会(ISSX)和中国药代专业委员会(CSSX)的战略合作协定,定于2013年5月17日至5月20日在河南大学召开第四届ISSX/CSSX学术会议。
1 | 学术演讲和研讨会 Symposiums and Panel Discussion 15个大会演讲 (30分钟) |
2 | 青年学者和学生演讲 Young Scholar and Student Presentation 48个分会场演讲 (30分钟),8个大会决赛演讲 (30分钟) |
3 | ADME相关单位展台 Booth Exhibition 20个展台 |
4 | ADME相关单位的午餐演讲会 Lunch Seminar 6个演讲 |
5 | 人才交流和招聘中心 Placement Center |
(一) 学术演讲和研讨会:
1. 药物相互作用研究:设计、数据分析、临床后果的推论(Drug Interaction Studies —Study Design, Data Analysis, and Implications for Dosing and Labeling)。由ISSX/CSSX邀请美国FDA官员和著名学者作三个学术报告,分别为:
a) 美国FDA药物相互作用研究的指导原则的建立依据和评审实践
b) 应用体外研究结果推测体内的临床潜在意义
c) 应用动物研究结果推测人临床潜在意义
演讲后安排2节课时间由演讲者和听众的自由互动讨论(PANEL DISCUSSION-1),以解决在新药研发中评价研究药物相互作用的具体问题。
该内容适于:从事新药研发和报批的专业人员,学者,学生。
2. 药物转运性药物相互作用研究:从研发到上市的意义和实践(Research and Evaluation of Transporter Based Drug-Drug Interaction: Significances and Applications from discovery to NDA)。由ISSX/CSSX邀请美国FDA官员和著名学者作三个学术报告,分别为:
a) 药物转运性相互作用的评价研究及其与药物代谢性相互作用的贡献
b) 药物转运性相互作用的评价研究中的三大决策程序(肠ABC转运体MDR1, MRP2; 肝SLC转运体OATP1B1, 1B3; 肾SLC转运体OAT1, OAT3和OCT2):我们能从中学到什么?
c) 涉及药物吸收的转运性相互作用的机制
演讲后安排2节课时间由演讲者和听众的自由互动讨论(PANEL DISCUSSION-2),以解决在转运性相互作用中的具体问题,如转运体选择、制备、试验设计、结果分析。
该内容适于:从事新药研发专业人员,学者,学生
3. 基于药物相互作用的个体化用药 – 在医院中对于已经上市的临床药物,如何研究它们的相互作用及评价其临床后果(DDI based personalized medication – How to design and conduct DDI study, and evaluate clinical consequences for marked therapeutics in hospitals)。由ISSX/CSSX邀请美国FDA官员和著名学者作三个学术报告,分别为:
a) 药物相互作用的种属差异及其在个体化用药中的应用
b) 药物相互作用的基因多态性及临床意义
c) 基于群体模型的PBPK研究及其在研发阶段和上市后阶段的应用
演讲后安排2节课时间由演讲者和听众的自由互动讨论(PANEL DISCUSSION-3),演讲者将通过具体的个案研究(CASE STUDY)讨论在临床药品中没有完善药物相互作用数据的情况下,如何应用体外研究、动物研究、临床研究和计算机模拟,从基因型和表现型机制,评估可能的药物相互作用引起的临床后果,指导个性化用药。包括中药/化药相互作用(HDI)和PBPK模拟和评估。
该内容适于:在医院中从事临床药学和临床药理学的专业人员,学者,学生。
(二) 青年学者和学生演讲和墙报:
1、墙报:邀请青年学者和学生通过墙报方式,介绍他们的研究工作
2、演讲:邀请并安排8组48个年轻学者或研究生的学术报告(20分钟演讲,10钟专家评价)。每组安排2-3名专家,就学术问题和演讲技巧进行零距离的指导和培训。从48个演讲中,评选一等奖(1个),二等奖(2个),三等奖(5个)。演讲领域包括(不限于)下列领域。
·CYP450的药物代谢及相互作用研究
·二相酶药物代谢及相互作用研究
·在药物安全评价中的药物代谢及相互作用研究
·放射性同位素ADME的研究
·代谢产物鉴定和结构解析
·化学药和大分子药的定量分析方法学
·药物代谢及相互作用的临床研究
·中药代谢/运转和药物相互作用研究
3、墙报和演讲比赛报名程序
凡未公开发表并与本次会议议题相关的研究论文、专题报告、综述及评述等均可投稿,请先把中英文摘要包括目的、方法、结果和结论送 star.yang@mice-partners.com 安排审阅。由青年学者和学生论文审查和评选委员会审阅后通知参加者。 。
4、墙报和演讲语言要求
语言要求全部用英文写作和演讲。
青年学者和学生墙报和演讲报名截止期:4月30日。
(三) 厂商展台:
为ADME的科研人员和相关厂商的互动,安排20个展位,使仪器、设备、试剂、耗材、软件、服务厂商,与使用者零距离互动,促进科研和产品服务优化更新。
(四) 午餐演讲会:
安排6个午餐演讲会,演讲会为两类: (1)邀请相关厂商,在午餐时,在ADME相关的仪器、设备、耗材、试剂、软件、外包服务的相关领域,分享他们成功经验,解答听众相关的问题。(2)邀请相关用人单位,在午餐时,向潜在的应聘者结束用人单位的情况和解答相关问题。
(五) 人才交流和招聘中心:
会议建立人才交流和招聘中心。张贴招人单位的招聘启事,收集应聘者的简历,在会场安排面试机会和场地。
二、组织机构
组委会共同主席
Dr. Bill Smith, President of ISSX (Pfizer, USA)
胡卓汉教授,中国药物代谢专业委员会副主席/瑞德肝脏疾病研究/复旦大学
许启泰教授,河南大学药学院
学术委员会共同主席
Dr. John Minors, Elected President of ISSX, Flinders University School of Medicine (Australia)
刘昌孝院士,中国药物代谢专业委员会荣誉主任委员,河南大学药学院名誉院长
张振清教授,中国药物代谢专业委员会主任委员
青年学者和学生论文审查和评选委员会共同主席
钟大放教授,中国药物代谢专业委员会副主任委员/中科院上海药物所
Prof. Russ Prough, Former President of ISSX (Univ. Louisville, USA)
程子强博士,Member of Membership Committee of ISSX阿斯利康制药(中国)
三、会议议程:
May 16, 2013, Thursday , Convention Centers of Henan University | |
All Day | Registration |
May 17, 2013, Friday , Convention Centers of Henan University | |
0730- 0820 | Registration |
0820-0830 | Opening Ceremony: |
0830-1000 | Symposium 1 Drug-drug interactions: Challenges, solutions and guidance Chaired by Dr. Bill Smith and Dr. Qingli Wang (Chinese FDA) l Regulatory Consideration for DDI evaluation by Dr. Lei Zhang (USFDA) l Prediction of in vivo DDI based on in vitro data by Dr. Wei Tang (ChemPartner, China) l Animal model for prediction human DDI by Dr. Bill Smith (Pfizer, USA) |
1000-1030 | Café Break and Poster Presentation / Booth exhibition |
1030-1130 | Panel Discussion 1 How to guide and review DDI for drug candidates – Experiences, Questions, & Answers ? Panel Members: l Dr. Haixue Wang (Chinese FDA) l Dr. Lei Zhang (USFDA) l Dr. Bill Smith (Pfizer USA) l Dr. Wei Tang (ChemPartner, China) l Dr. Sonia de Morais (Abbot Lab, USA) l Dr. Ziwei Zhao (J & J, China) l Dr. Hongshi Yu (Wuxiappec, China) |
1130-1200 | Scientific Presentation by Golden Sponsor 1 |
1200-1330 | Lunch symposium by Silver sponsor 1 Lunch symposium by Silver sponsor 2 ISSX/CSSX Lunch Working Meeting |
1330-1500 | Symposium 2 Research and Evaluation of Transporter Based Drug-Drug Interaction: Significances and Applications from discovery to NDA Chaired by Dr. Jasminder Sahi and Dr. Kexin Liu l Mechanism of Interaction by absorptive transporters by Dr. Ikumi Tamai (Kanazawa Univ. Japan) l Application of Decision Tree: What we can learn by Dr. Caroline A Lee (Independent, USA) l Evaluation of Drug Transporters and Interplays with Drug metabolism enzymes by Dr. Jasminder Sahi (GSK, China) |
1500-1530 | Café Break and Poster Presentation / Booth exhibition |
1530-1640 | Panel Discussion 2 Guidance, Study Design, Procedure, Data Analysis, Report Preparation for evaluating transporter based DDI Panel Members: l Dr. Jasminder Sahi (GSK, China) l Dr. Ikumi Tamai (Kanazawa Univ. Japan) l Dr. Sonia de Morais (Abbot Lab , USA) l Dr. Lei Zhang (USFDA) l Dr. Genfu Chen (Wuxiappec, China) l Dr. Noriaki Shimada (Genomembarne, Japan) |
1640-1700 | Scientific presentation by Golden sponsor 2 |
1700-1730 | Booth exhibition and Poster Presentation |
1830-2100 | Reception |
May 18, 2013, Saturday , Convention Centers of Henan University | |
0830-1000 | Symposium 3 DDI based personalized medication Chaired by Dr. John Minors and Dr. Min Huang l Drug-drug interactions - Therapeutic drug monitoring by Dr. John Minors (Flinders University, Australia) l Evaluation of Inter-ethnic differences in DDI and application in personalized medication by Dr. Geoff Tucker (Manchester Univ. UK) l ADME pharmacogenomics and clinical impacts in drug safety and efficacy by Dr. Liangfu Chen (GlaxoSmithKline, R&D China, Shanghai) l Population-based PBPK study and its application in discovery, development and post marketing by a senior person (Roche, USA) |
1000-1030 | Café Break and Poster Presentation / Booth exhibition |
1030-1140 | Panel Discussion 3 DDI based personalized medication – How to design and conduct DDI study, and evaluate clinical consequences for marked therapeutics in hospitals Panel Members: l Dr. John Minors (Flinders University, Australia) l Dr. Min Huang (Zhong Shan Univ. China) l Dr. Geoff Tucker (Manchester Univ. UK) l Dr. Jing Yang (Chinese FDA) l Dr. Jianson Yang (GSK, China) l Dr. Qianzhou Lu (Fudan Univ. China) l Dr. Liangfu Chen (GSK, China) |
1130-1200 | Scientific presentation by Golden Sponsor 3 |
1200-1330 | Lunch symposium 3 Lunch symposium 4 |
1330-1700 | Young Scholar & Student Presentation – 1st round (48 speakers in 8 groups) Including Café bread and Booth Exhibition from 1500-1530 |
l Group 1: Dr. Bill Smith, Dr. Zhiqiang Cheng (AZ, China) l Group 2: Dr. Russ Prough and Dr. Su Zeng (Zhejiang Univ. China) l Group 3: Dr. Dan Draden and Dr. Dafang Zhong (SIMM, China) l Group 4: Dr. Jasminder Sahi and Dr. Kexin Liu l Group 5: Dr. Noriaki Shimada and Dr. Weiqing Chen (ChemPartners) l Group 6: Dr. Geoff Tucker and Dr. Jiansong Yang l Group 7: Dr. Sonia de Morais and Dr. Ge Lin (Hong Kong Chinese Univ. China) l Group 8: Dr. Ikumi Tamai and Dr. Chuan Li | |
1700-1730 | Awarding committee meeting for selecting the best presentation candidates: Co-chairs from 8 group |
1830-2100 | Banquet and Performance by attendants (Dining Table arranged per Group) |
May 19, 2013, Sunday, Convention Centers of Henan University | |
0830-1000 | Symposium 4A Drug-Drug Interaction (DDI) and Safety Evaluation Chaired by Dr. Sonia de Morais and Dr. Zhenqing Zhang (CSSX) Speakers: l Dr. Sonia deMorais (Abbott Lab, USA) l Dr. Duanyun Si (Tianjing Center for Drug Safety Evaluation & Research) l Dr. Lijie Fu (SBAL, China) Symposium 4B: Herb-Drug Interaction (HDI) and Safety/Clinical significances l Dr. Chuan Li, (Chinese Academy of Chinese Traditional Medicines, China) l Dr. Ge Lin (The Chinese University of Hong Kong, HK) l To be determined |
1000-1030 | Café Break and Booth exhibition |
1030-1200 | Young Scholar & Student Presentation – Finals (8 speakers from 1st round) Chaired by Dr. John Minors and Dr. Dafang Zhong |
Speaker from Group 1 Speaker from Group 2 Speaker from Group 3 | |
1230-1330 | Lunch symposium 5 Lunch symposium 6 |
1330-1600 | Young Scholar & Student Presentation – Finals (Continue) Chaired by Dr. Bill Smith and Dr. Zhuohan Hu |
Speaker from Group 4 Speaker from Group 5 Speaker from Group 6 Speaker from Group 7 Speaker from Group 8 | |
1600-1630 | Café Break and Booth exhibition Awarding Committee Meeting for selecting 1st Award, 2nd Award, and 3rd Award |
1630-1730 | Panel Discussion: How to prepare and present your research work in English and Case Studies for selected presentation from this Workshop Panel Member: l Dr. Bill Smith l Dr. Russ Prough l Dr. Sonia deMorais l Dr. Geoff Tucker l Dr. Ikumi Tamai l Dr. Jasminder Sahi |
1730 | Awarding chaired by and Dr. Russ Prough (ISSX) and Dr. Changxiao Liu (CSSX) Close Remark by Dr. Bill Smith (ISSX) and Dr. Zhenqing Zhang (CSSX) |
1830-2100 | Dinner and Civic Performance |
四、会议注册
1、会议注册费(含资料费)
正式代表1000元/人(ISSX会员800元/人);学生500元/人(ISSX会员300元/人)。
以上费用为会议注册费,交通和住宿费用自理。因本次会议规模大,参会人数多,组委会以实际收到会务费为报名和安排住宿依据。
2、缴纳注册费方式(待进一步通知)
请注明“CSSX-ISSX会议注册费”和参会人姓名、单位。
提前注册和缴费截止日期:2013年5月10日。请各位参会代表务必在5月12日前缴纳会议注册费。
五、青年学者演讲和墙报奖学金和奖金设置
1、演讲比赛奖项设置
一等奖:1人,奖金1000元
二等奖:2人,奖金800元/人
三等奖:5人,奖金700元/人
优秀奖:40人,奖金500元/人
2、墙报奖学金
凡墙报被接受并在现场展示的青年学者或学生,将获得500元奖学金。
注:演讲比赛奖金和墙报展示奖学金不可兼得。
墙报上述奖项将在会议闭幕式期间举行颁奖仪式。
如有任何问题和建议,请与下列工作人员联系
胡卓汉(组委会) huzh@rild-biotech.com,
张振清(学术委员会)yzlimm@tom.com,
谢纳泽(河南大学药学院)xnz@henu.edu.cn,
冯军豪(上海逸星商务咨询有限公司) frank.fung@mice-partners.com,